SIGA TECHNOLOGIES INC (SIGA)

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

Address

31 EAST 62ND STREET
NEW YORK, NY 10065

Founded

1995

Number of Employees

45

Website

http://www.siga.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )		 - - - - - - $28,498 $26,025 $13,000 $10,972 - $19,624
Average Price - - - - - - $6.16 $6.87 $7.13 $6.32 - $6.55
# Shares Purchased - - - - - - 4,628,473 3,787,683 1,823,738 1,736,822 - 2,994,179
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - - - - - - 13.7% 1.9% -1.8% 10.8% - 6.8%
S&P 500 Return to Date - - - - - - 74.8% 31.7% 37.3% 31.3% - 43.8%
Excess Total Return - - - - - - -61.1% -29.8% -39.1% -20.5% - -37.0%
Quartile Rank
Percentile Rank - - - - - - 37% 47% 44% 50% - 46%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
CHIMERIX INC
STERN ANDREW L

SIGA TECHNOLOGIES INC
VERU INC.
MACANDREWS & FORBES INC.

SIGA TECHNOLOGIES INC